Down 9.2% in 4 Weeks, Here's Why You Should You Buy the Dip in ResMed (RMD)Zacks Investment Research • 01/10/22
ResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/03/22
ResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted ConferenceGlobeNewsWire • 12/30/21
ResMed Inc.: Another Example Of Best Medical Devices Near-Term Buy - As Seen By Market-MakersSeeking Alpha • 12/05/21
ResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of DirectorsGlobeNewsWire • 11/19/21
ResMed Announces Participation in the Credit Suisse 30th Annual Healthcare ConferenceGlobeNewsWire • 11/03/21
ResMed Inc. (RMD) CEO Mick Farrell on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 10/29/21
ResMed Inc.: Best Price-Positioned Medical Supply Industry Stock, As Seen By Market-MakersSeeking Alpha • 09/17/21
People with Sleep Apnea Live Longer on CPAP in Large, Late-Breaking ResMed-Supported ALASKA Study Presented at ERSGlobeNewsWire • 09/08/21
ResMed Announces Participation in the Morgan Stanley 19th Annual Global Healthcare ConferenceGlobeNewsWire • 09/02/21